| pubmed-article:9796765 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9796765 | lifeskim:mentions | umls-concept:C1138603 | lld:lifeskim |
| pubmed-article:9796765 | lifeskim:mentions | umls-concept:C1858460 | lld:lifeskim |
| pubmed-article:9796765 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:9796765 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
| pubmed-article:9796765 | lifeskim:mentions | umls-concept:C0376629 | lld:lifeskim |
| pubmed-article:9796765 | lifeskim:mentions | umls-concept:C0373538 | lld:lifeskim |
| pubmed-article:9796765 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9796765 | pubmed:dateCreated | 1998-12-30 | lld:pubmed |
| pubmed-article:9796765 | pubmed:abstractText | The maternal serum alpha-fetoprotein test (MSAFP) was developed to screen for neural tube defects. Little is known about the adoption of the MSAFP test. This study examines the effect of provider specialty and geographic location and patient insurance status on MSAFP test use in Washington State. | lld:pubmed |
| pubmed-article:9796765 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9796765 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9796765 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9796765 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9796765 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9796765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9796765 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9796765 | pubmed:issn | 0893-8652 | lld:pubmed |
| pubmed-article:9796765 | pubmed:author | pubmed-author:RosenblattR... | lld:pubmed |
| pubmed-article:9796765 | pubmed:author | pubmed-author:HartL GLG | lld:pubmed |
| pubmed-article:9796765 | pubmed:author | pubmed-author:BaldwinL MLM | lld:pubmed |
| pubmed-article:9796765 | pubmed:author | pubmed-author:RaineT RTR | lld:pubmed |
| pubmed-article:9796765 | pubmed:author | pubmed-author:FordyceM AMA | lld:pubmed |
| pubmed-article:9796765 | pubmed:author | pubmed-author:Jenkins-Woelk... | lld:pubmed |
| pubmed-article:9796765 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9796765 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:9796765 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9796765 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9796765 | pubmed:pagination | 357-65 | lld:pubmed |
| pubmed-article:9796765 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:meshHeading | pubmed-meshheading:9796765-... | lld:pubmed |
| pubmed-article:9796765 | pubmed:articleTitle | Influence of provider characteristics and insurance status on maternal serum alpha-fetoprotein screening. | lld:pubmed |
| pubmed-article:9796765 | pubmed:affiliation | Duke University Department of Family and Community Medicine, Chapel Hill, USA. | lld:pubmed |
| pubmed-article:9796765 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9796765 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9796765 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
